Curative Biotechnology Stock Buy Hold or Sell Recommendation
| CUBT Stock | USD 0.01 0.0003 2.22% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Curative Biotechnology is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Curative Biotechnology given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Curative Biotechnology, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Curative Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Curative Stock please use our How to Invest in Curative Biotechnology guide. Note, we conduct extensive research on individual companies such as Curative and provide practical buy, sell, or hold advice based on investors' constraints. Curative Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Curative |
Execute Curative Biotechnology Buy or Sell Advice
The Curative recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Curative Biotechnology. Macroaxis does not own or have any residual interests in Curative Biotechnology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Curative Biotechnology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Curative Biotechnology Trading Alerts and Improvement Suggestions
| Curative Biotechnology is way too risky over 90 days horizon | |
| Curative Biotechnology has some characteristics of a very speculative penny stock | |
| Curative Biotechnology appears to be risky and price may revert if volatility continues | |
| Curative Biotechnology has high likelihood to experience some financial distress in the next 2 years | |
| Curative Biotechnology currently holds 2.26 M in liabilities with Debt to Equity (D/E) ratio of 6.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curative Biotechnology has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Curative Biotechnology's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 132.32 K. Net Loss for the year was (3.96 M) with profit before overhead, payroll, taxes, and interest of 100.21 K. | |
| Curative Biotechnology currently holds about 126.85 K in cash with (486.58 K) of positive cash flow from operations. |
Curative Biotechnology Returns Distribution Density
The distribution of Curative Biotechnology's historical returns is an attempt to chart the uncertainty of Curative Biotechnology's future price movements. The chart of the probability distribution of Curative Biotechnology daily returns describes the distribution of returns around its average expected value. We use Curative Biotechnology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Curative Biotechnology returns is essential to provide solid investment advice for Curative Biotechnology.
| Mean Return | 1.30 | Value At Risk | -23.74 | Potential Upside | 26.36 | Standard Deviation | 14.11 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Curative Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Curative Biotechnology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Curative Biotechnology or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Curative Biotechnology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Curative stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.26 | |
β | Beta against Dow Jones | 2.42 | |
σ | Overall volatility | 14.11 | |
Ir | Information ratio | 0.09 |
Curative Biotechnology Volatility Alert
Curative Biotechnology is showing large volatility of returns over the selected time horizon. Curative Biotechnology is a penny stock. Although Curative Biotechnology may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Curative Biotechnology. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Curative instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Curative Biotechnology Fundamentals Vs Peers
Comparing Curative Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Curative Biotechnology's direct or indirect competition across all of the common fundamentals between Curative Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Curative Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Curative Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Curative Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Curative Biotechnology to competition |
| Fundamentals | Curative Biotechnology | Peer Average |
| Return On Equity | -3.98 | -0.31 |
| Return On Asset | -0.52 | -0.14 |
| Current Valuation | 13.74 M | 16.62 B |
| Shares Outstanding | 903.26 M | 571.82 M |
| Shares Owned By Insiders | 0.05 % | 10.09 % |
| Price To Sales | 158.53 X | 11.42 X |
| Revenue | 132.32 K | 9.43 B |
| Gross Profit | 100.21 K | 27.38 B |
| EBITDA | (2.5 M) | 3.9 B |
| Net Income | (3.96 M) | 570.98 M |
| Cash And Equivalents | 126.85 K | 2.7 B |
| Total Debt | 2.26 M | 5.32 B |
| Debt To Equity | 6.60 % | 48.70 % |
| Current Ratio | 0.10 X | 2.16 X |
| Book Value Per Share | (0) X | 1.93 K |
| Cash Flow From Operations | (486.58 K) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 4 | 18.84 K |
| Beta | 214.95 | -0.15 |
| Market Capitalization | 12.47 M | 19.03 B |
| Total Asset | 2.6 M | 29.47 B |
| Retained Earnings | (38.23 M) | 9.33 B |
| Working Capital | (4.42 M) | 1.48 B |
| Net Asset | 2.6 M |
Curative Biotechnology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Curative . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0857 | |||
| Daily Balance Of Power | 0.25 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.0134 | |||
| Day Typical Price | 0.0135 | |||
| Market Facilitation Index | 0.0012 | |||
| Price Action Indicator | 6.0E-4 | |||
| Period Momentum Indicator | 3.0E-4 | |||
| Relative Strength Index | 56.56 |
About Curative Biotechnology Buy or Sell Advice
When is the right time to buy or sell Curative Biotechnology? Buying financial instruments such as Curative Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Curative Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.